Scarica l'app Stockscreener
77.81
1.80%
-1.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$79.24
Aprire:
$79.39
Volume 24 ore:
5.17M
Relative Volume:
0.73
Capitalizzazione di mercato:
$98.69B
Reddito:
$393.94B
Utile/perdita netta:
$428.00M
Rapporto P/E:
203.37
EPS:
0.3826
Flusso di cassa netto:
$6.29B
1 W Prestazione:
-1.49%
1M Prestazione:
-2.32%
6M Prestazione:
+29.60%
1 anno Prestazione:
+41.24%
Intervallo 1D:
$77.75
$79.74
Intervallo di 1 settimana:
$76.50
$81.72
Portata 52W:
$43.56
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
77.81 | 100.59B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
321.86 | 301.21B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
325.83 | 72.96B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
269.66 | 72.36B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
237.12 | 28.47B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Why One Fund Just Invested $21 Million in This Once High-Flying Software Stock - The Motley Fool
Can CVS Health Corporation (Common Stock) (CVS0) stock deliver consistent EPS growthTake Profit & Technical Pattern Based Buy Signals - newser.com
TD Cowen Lifts CVS Health Corporation (CVS) Price Target amid Record Q3 Revenue - Insider Monkey
What the charts say about CVS Health Corporation todayQuarterly Portfolio Summary & Reliable Intraday Trade Plans - newser.com
How CVS Health Corporation (Common Stock) (CVS0) stock reacts to monetary easingMarket Risk Summary & Weekly High Potential Stock Alerts - newser.com
Will CVS Health Corporation (CVS) stock beat revenue estimatesWeekly Trade Recap & Accurate Trade Setup Notifications - newser.com
CVS Reaches Deal In 'Non-Drowsy' Labeling Class Action - Law360
Should you wait for a breakout in CVS Health CorporationJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com
Is CVS Health Corporation stock supported by strong fundamentalsWeekly Profit Summary & Daily Risk Controlled Trade Plans - newser.com
CVS Health (CVS) Analyst Rating: Wells Fargo Lowers Price Target | CVS Stock News - GuruFocus
The Bull Case For CVS Health (CVS) Could Change Following Raised Earnings Guidance and Key Segment Strength - Yahoo Finance
Stock of the weekCVS Health Corp (13.11.2025) - XTB.com
Is CVS Health Corporation (CVS) stock a contrarian opportunityJuly 2025 Recap & Capital Protection Trade Alerts - newser.com
LLY: Eli Lilly Stock Climbs After Exiting CVS Drug Plan - Yahoo Finance
CVS Health Better See Its General Practitioner For a Check Up - TheStreet Pro
Can CVS Health Corporation (Common Stock) (CVS0) stock double in coming years2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. - AOL.com
Eli Lilly drops CVS drug plan for staff after Novo obesity deal, Bloomberg News reports - Reuters
3 Stocks That Have Made Epic Comebacks in 2025 - AOL.com
Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch - Benzinga
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'CVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Eli Lilly Stock Jumps Premarket On Dumping CVS Drug Plan After Wegovy Snub — Retail Calls It A Pushback Against PBM Power - MSN
Eli Lilly Removes CVS from Employee Drug Plan Following Weight-Loss Drug Snub - Meyka
Eli Lilly drops CVS as employee drug plan after weight-loss drug snubreport - Investing.com
Lilly Drops CVS Drug Plan for Workers After Novo Deal - Bloomberg.com
Lilly Drops CVS Drug Plan for Workers After Novo Obesity Deal - Bloomberg.com
Why Guardian Pharmacy Services Stock Was on a Tear Tuesday - AOL.com
CVS Health Lifts Adjusted EPS Outlook: What's Driving It? - Yahoo Finance
CVS Health Is Soaring 75% This Year. And the Stock Still Looks Cheap. - AOL.com
Pete Buttigieg Slams Trump's 'Bad Deal' On Health Insurance, Cites CBO Estimate Of 10% Premium Hikes: 'Losing On The Economy' - Benzinga
Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December - Benzinga
Judge says CVS Pharmacy must face class action lawsuit alleging it unlawfully tracked health data of online users - Class Action Lawsuits
CVS Health (NYSE: CVS) to outline 2025–2026 guidance at Investor Day with webcast - Stock Titan
How the Changing Story Could Impact CVS Health’s Valuation and Growth Prospects - Yahoo Finance
Mitsubishi UFJ Asset Management Co. Ltd. Raises Position in CVS Health Corporation $CVS - MarketBeat
Metis Global Partners LLC Trims Holdings in CVS Health Corporation $CVS - MarketBeat
Savant Capital LLC Has $3.81 Million Position in CVS Health Corporation $CVS - MarketBeat
How CVS Health Corporation stock performs in rate cut cyclesJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
Is CVS Health Corporation (Common Stock) (CVS0) stock a safe buy pre earningsDividend Hike & Safe Capital Growth Plans - newser.com
Rite Aid Patient Files Acquired by CVS - SNJ Today
CVS Health’s CFO Is Leaving as Pharmacy Chain Faces Activist Investor - MSN
Will CVS Health Corporation bounce back from current supportRisk Management & Reliable Entry Point Trade Alerts - newser.com
5,999 Shares in CVS Health Corporation $CVS Purchased by Efficient Advisors LLC - MarketBeat
CVS Health Corporation $CVS Shares Bought by Aviva PLC - MarketBeat
CVS Health Corporation $CVS Shares Acquired by AE Wealth Management LLC - MarketBeat
S&T Bank PA Cuts Stake in CVS Health Corporation $CVS - MarketBeat
Twin Capital Management Inc. Purchases 10,795 Shares of CVS Health Corporation $CVS - MarketBeat
Resona Asset Management Co. Ltd. Increases Holdings in CVS Health Corporation $CVS - MarketBeat
SouthState Corp Sells 4,588 Shares of CVS Health Corporation $CVS - MarketBeat
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.75%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):